GBS Type III polysaccharide-tetanus toxoid conjugate vaccine (Formulation 2)

· National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GBS Type III polysaccharide-tetanus toxoid conjugate vaccine (Formulation 2), covering 2010-08-27 to 2010-08-27. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines [Phase 1]

See pricing